Are you curious about the potential therapeutic benefits of psychedelic-assisted therapy? Tune in to this week's episode of our podcast, where we have a fascinating conversation with Dr. Graham Campbell, a renowned consultant psychiatrist and researcher in the field.

Drawing from his extensive experience in both psychedelic research and clinical work, Dr. Campbell shares his insights on a range of topics. Discover his thoughts on the possibility of introducing psychedelic treatments by the NHS, the differences between magic mushrooms and DMT in the treatment of depression, and the crucial role of music in a psychedelic journey.

Join us for an engaging and informative discussion on the cutting-edge of psychedelic-assisted therapy, with one of the leading experts in the field. Don't miss out - listen to our latest episode now!

Listen to Graham's music here!

 Psychedelic Assisted Therapy

 Small Pharma

 DMT

 Ketamine

 Intranasal Esketamine (SpravatoTM) for Use in Treatment-Resistant Depression In Conjunction With an Oral Antidepressant

 Schizophrenia

 Bipolar disorder

 Schizoaffective disorder

 Trial of Psilocybin versus Escitalopram for Depression

 Rosalind Watts

 Michelle Baker Jones

 Roberta Murphy 

 Jonny Martell

 Ashleigh Murphy-Beiner

 Psilocybin

 Institute of Psychedelic Therapy

 The Readiness of Psychiatrists to Implement Psychedelic-Assisted Psychotherapy

 Sussex Partnership NHS Foundation Trust

 Ayahuasca

 Monoamine oxidase inhibitor

 Serotonin 

 The ACE Model

 The hidden therapist: evidence for a central role of music in psychedelic therapy

 Max Cooper

 Music and the Mind by Anthony Storr

 Mind Foundation

 Maria Papaspyrou